Home

MEI Pharma, Inc. - Common Stock (MEIP)

6.9986
+0.4486 (6.85%)
NASDAQ · Last Trade: Jul 22nd, 9:45 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
MEI Pharma Trades Cash For LTCstocktwits.com
Via Stocktwits · July 22, 2025
These stocks have an unusual volume in today's sessionchartmill.com
On Monday, there are stocks with unusual volume. Let's take a look.
Via Chartmill · July 21, 2025
US Stocks Likely To Open Higher Despite Trump Administration's 'Hard Deadline' Warning For Tariffs — Verizon, Domino's Pizza Earnings In Focusbenzinga.com
U.S. stock futures were positive on Monday after ending mostly lower on Friday. Futures of major benchmark indices were higher.
Via Benzinga · July 21, 2025
Why Is MEI Pharma Stock Soaring On Friday?benzinga.com
MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the average volume of 29.8K, as per data from Benzinga Pro.
Via Benzinga · July 18, 2025
Earnings Outlook For MEI Pharmabenzinga.com
Via Benzinga · September 25, 2023
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · July 18, 2025
Dow Falls Over 200 Points; 3M Earnings Top Viewsbenzinga.com
Via Benzinga · July 18, 2025
MEI Pharma Announces $100M Placement To Initiate Litecoin Treasury Strategy: Retail Cheers Charlie Lee’s Addition To Company Boardstocktwits.com
MEI Pharma intends to use the funds to acquire the native cryptocurrency of the Litecoin blockchain, commonly referred to as “LTC”, which will serve as the company’s primary treasury reserve asset.
Via Stocktwits · July 18, 2025
First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Assetbenzinga.com
MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and
Via Benzinga · July 18, 2025
US Stocks Mixed; American Express Posts Upbeat Q2 Resultsbenzinga.com
Via Benzinga · July 18, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 17, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 30, 2025
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Miningmarkets/com
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.
Via Benzinga · November 22, 2024
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foulbenzinga.com
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.
Via Benzinga · November 17, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 25, 2024
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 22, 2024
7 Undervalued Biotech Stocks to Buy for Big-Time Returnsinvestorplace.com
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Via InvestorPlace · July 1, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · May 16, 2024
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024investorplace.com
MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024.
Via InvestorPlace · May 9, 2024
5 Value Stocks In The Healthcare Sectorbenzinga.com
Via Benzinga · February 19, 2024
A Look Into Healthcare Sector Value Stocksbenzinga.com
Via Benzinga · January 8, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 16, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 16, 2023
Earnings Scheduled For September 26, 2023benzinga.com
Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is estimated to report quarterly earnings at $2.46 per share on revenue of $7.60 billion.
Via Benzinga · September 26, 2023
Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Mergerbenzinga.com
Infinity Pharmaceuticals Inc (NASDAQ: INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the 
Via Benzinga · July 10, 2023